KEARNY, NJ -- Proprietary Nutritionals Inc. (PNI) has announced that a research study conducted with Celadrin®, a proprietary blend of special fatty acids lauded for its ability to promote joint health, found that using Celadrin cream for 21 days can visually improve facial and skin appearance.

The study, titled “The Effects of Celadrin® Topical Cream Treatment to Improve Facial Skin Appearance,” was commissioned by its developer, Imagenetix, Inc., and concluded that Celadrin works to “regenerate the skin by enhancing the lipid structure of the cell membrane, enabling the cells to rapidly repair and regenerate.”

“The majority of OTC skin care products contain common anti-oxidants, like Vitamin C and E, combined with newer compounds such as lipoic acid,” said Dean Mosca, President of PNI. “Little, if any, research has been conducted regarding the efficacy of these products. The primary goal of this new study was to demonstrate improvement in combating visible signs of aging, and it showed that after 21 days of use, Celadrin had penetrated every layer of the skin, and helped to improve the hydration, resiliency, elasticity and firmness of the skin.”

According to Dean Mosca, president of PNI, marketer of Celadrin, “The results of this initial study are encouraging and support the use of Celadrin as a natural way to treat age-related facial skin problems.”

Proprietary Nutritionals, Inc., a joint venture with Pharmachem Laboratories, Inc., is located in Kearny, NJ. PNI markets Celadrin® Joint Flexibility & Relief, and other patented, scientifically proven, branded ingredients to the nutraceuticals industry. For further information, visit www.celadrin.com, or call 519/647-2071.